This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Benzinga·07/25/2025 12:34:15
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Needham analyst Ryan Koontz initiated coverage on Applied Optoelectronics, Inc. (NASDAQ:AAOI) with a Buy rating and announced a price target of $32. Applied Optoelectronics shares closed at $25.84 on Thursday. See how other analysts view this stock.
Goldman Sachs analyst Richard Law initiated coverage on Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) with a Neutral rating and announced a price target of $18. Arcutis Biotherapeutics shares closed at $15.02 on Thursday. See how other analysts view this stock.
Mizuho analyst Steven Valiquette initiated coverage on Teladoc Health, Inc. (NYSE:TDOC) with a Neutral rating and announced a price target of $10. Teladoc Health shares closed at $8.20 on Thursday. See how other analysts view this stock.
Piper Sandler analyst Brent Bracelin initiated coverage on Palantir Technologies Inc. (NASDAQ:PLTR) with an Overweight rating and announced a price target of $170. Palantir Technologies shares closed at $154.86 on Thursday. See how other analysts view this stock.
Jefferies analyst Brian Tanquilut initiated coverage on Chemed Corporation (NYSE:CHE) with a Hold rating and announced a price target of $500. Chemed shares closed at $463.02 on Thursday. See how other analysts view this stock.
Considering buying PLTR stock? Here’s what analysts think:
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.